共 96 条
[1]
O’Gara PT(2013)2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 e362-425
[2]
Kushner FG(2018)2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 39 119-177
[3]
Ascheim DD(2018)PPIs are not responsible for elevating cardiovascular risk in patients on clopidogrel-A systematic review and meta-analysis Front Physiol 9 1550-482
[4]
Casey DE(2011)Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry Circulation 123 474-386
[5]
Chung MK(2010)Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study Ann Intern Med 153 378-9
[6]
de Lemos JA(2019)Cohort profile: the Swedish Prescribed Drugs and Health Cohort (SPREDH) BMJ Open 9 e023155-33
[7]
Ibanez B(2017)Nordic registry-based cohort studies: Possibilities and pitfalls when combining Nordic registry data Scand J Public Health 45 14-908
[8]
James S(2011)External review and validation of the Swedish national inpatient register BMC Public Health 11 450-773
[9]
Agewall S(2009)The completeness of the Swedish Cancer Register: a sample survey for year 1998 Acta Oncol 48 27-1917
[10]
Antunes MJ(2015)Tumour staging of oesophageal cancer in the Swedish Cancer Registry: a nationwide validation study Acta Oncol 54 903-260